Assessing the Effectiveness of Pharmacist-Directed Medication Therapy Management in Improving Diabetes Outcomes in Patients With Poorly Controlled Diabetes

The Diabetes Educator

Volumn 41, Issue 4, 2015, Pages 459-465

  Skinner, Jeannine S ^a   Poe, Brett ^a   Hopper, Rebecca ^b   Boyer, Alaina ^a   Wilkins, Consuelo H ^a,c  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b Pulmonary Disease Program   (United States)

^c MEHARRY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; CREATININE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; LIPID;

AGED; BLOOD; BLOOD PRESSURE; CASE CONTROL STUDY; DIABETES MELLITUS, TYPE 2; FEMALE; HUMAN; MALE; MEDICATION COMPLIANCE; MEDICATION THERAPY MANAGEMENT; MIDDLE AGED; PHARMACIST; PHARMACY; PROGRAM EVALUATION; PSYCHOLOGY; RETROSPECTIVE STUDY;

AGED; BLOOD PRESSURE; CASE-CONTROL STUDIES; CREATININE; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; LIPIDS; MALE; MEDICATION ADHERENCE; MEDICATION THERAPY MANAGEMENT; MIDDLE AGED; PHARMACEUTICAL SERVICES; PHARMACISTS; PROGRAM EVALUATION; RETROSPECTIVE STUDIES;

EID: 84943176769     PISSN: 01457217     EISSN: 15546063     Source Type: Journal    
DOI: 10.1177/0145721715587563     Document Type: Article

References (24)

1. McWilliams JM. Health consequences of uninsurance among adults in the United States: recent evidence and implications. Milbank Q. 2009;87(2):443-494.
2. Brown AF, Ettner SL, Piette J et al. Socioeconomic position and health among persons with diabetes mellitus: a conceptual framework and review of the literature. Epidemiol Rev. 2004;26:63-77.
3. Chin MH. Quality improvement implementation and disparities: the case of the health disparities collaboratives. Med Care. 2010;48(8):668-675.
4. Card D, Dobkin C, Maestas N. The impact of nearly universal insurance coverage on health care utilization and health: evidence from Medicare. Am Econ Rev. 2004;98(5):2242-2258.
5. Freeman JD, Kadiyala S, Bell JF, Martin DP. The causal effect of health insurance on utilization and outcomes in adults: a systematic review of US studies. Med Care. 2008;46(10):1023-1032.
6. Center for Disease Control and Prevention—national diabetes statistics report, 2014—publications—diabetes DDT. http://www.cdc.gov/diabetes/pubs/statsreport14.htm. Accessed September 29, 2014.
7. National Association of Community Health Centers. A sketch of Community Health Centers Chart Book 2014. www.nachc.com. Accessed February 10, 2014.
8. Chung WW, Chua SS, Lai PSM, Chan SP. Effects of a pharmaceutical care model on medication adherence and glycemic control of people with type 2 diabetes. Patient Prefer Adherence. 2014;8:1185-1194.
9. Horswell RL, Wascom CK, Cerise FP, Besse JA, Johnson JK. Diabetes mellitus medication assistance program: relationship of effectiveness to adherence. J Health Care Poor Underserved. 2008;19(3):677-686.
10. Chua S, Chan S. Medication adherence and achievement of glycaemic targets in ambulatory type 2 diabetic patients. J Appl Pharm Sci. 2011;1(4):55-59.
11. Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care. 2004;27(5):1218-1224.
12. Lindenmeyer A, Hearnshaw H, Vermeire E, Van Royen P, Wens J, Biot Y. Interventions to improve adherence to medication in people with type 2 diabetes mellitus: a review of the literature on the role of pharmacists. J Clin Pharm Ther. 2006;31(5):409-419.
13. Bluml BM. Definition of medication therapy management: development of professionwide consensus. J Am Pharm Assoc. 2003;45(5):566-572.
14. American Diabetes Association. Standards of medical care in diabetes—2011. Diabetes Care. 2011;34(suppl 1):S11-S61.
15. Executive summary: standards of medical care in diabetes—2014. Diabetes Care. 2014;37(suppl 1):S5-S13.
16. Grant R, Adams AS, Trinacty CM et al. Relationship between patient medication adherence and subsequent clinical inertia in type 2 diabetes glycemic management. Diabetes Care. 2007;30(4):807-812.
17. Adams AS, Trinacty CM, Zhang F et al. Medication adherence and racial differences in A1C control. Diabetes Care. 2008;31(5):916-921.
18. Davidson MB, Karlan VJ, Hair TL. Effect of a pharmacist-managed diabetes care program in a free medical clinic. Am J Med Qual. 2000;15(4):137-142.
19. Skaer TL, Sclar DA, Markowski DJ, Won JK. Effect of value-added utilities on prescription refill compliance and Medicaid health care expenditures—a study of patients with non-insulin-dependent diabetes mellitus. J Clin Pharm Ther. 1993;18(4):295-299.
20. Odegard PS, Goo A, Hummel J, Williams KL, Gray SL. Caring for poorly controlled diabetes mellitus: a randomized pharmacist intervention. Ann Pharmacother. 2005;39(3):433-440.
21. Rhee MK, Slocum W, Ziemer DC et al. Patient adherence improves glycemic control. Diabetes Educ. 2005;31(2):240-250.
22. Bluml BM, Watson LL, Skelton JB, Manolakis PG, Brock KA. Improving outcomes for diverse populations disproportionately affected by diabetes: final results of Project IMPACT: diabetes. J Am Pharm Assoc. 2014;54(5):477-485.
23. Iyer R, Coderre P, McKelvey T et al. An employer-based, pharmacist intervention model for patients with type 2 diabetes. Am J Health Syst Pharm. 2010;67(4):312-316.
24. Garrett DG, Bluml BM. Patient self-management program for diabetes: first-year clinical, humanistic, and economic outcomes. J Am Pharm Assoc. 2003;45(2):130-137.